Cost-Minimisation Analysis of Paliperidone Palmitate Long-Acting Treatment versus Risperidone Long-Acting Treatment for Schizophrenia in Spain
Crossref DOI link: https://doi.org/10.1007/s40261-016-0393-z
Published Online: 2016-03-21
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Quintero, Javier
Oyagüez, Itziar
González, Beatriz
Cuervo-Arango, Ignacio
García, Ignacio
Casado, Miguel Angel
Funding for this research was provided by:
Janssen Spain
Text and Data Mining valid from 2016-03-21